Literature DB >> 8578615

Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo.

M M Teixeira1, T J Williams, P G Hellewell.   

Abstract

The presence of eosinophils and their products in tissues is frequently associated with the pathogenesis of allergic inflammation. A better understanding of how these cells are recruited from the microcirculation will help in the development of therapies targeted at allergic disorders. Here, Mauro Teixeira, Timothy Williams and Paul Hellewell describe the current concepts of eosinophil accumulation, examine the potential ways of modulating this process, and discuss whether antagonists of eosinophil-specific mediators or functional antagonists would be the preferred therapies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578615     DOI: 10.1016/s0165-6147(00)89092-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  11 in total

1.  A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.

Authors:  N Cooper; M M Teixeira; J Warneck; J M Miotla; R E Wills; D M Macari; R W Gristwood; P G Hellewell
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin.

Authors:  M M Teixeira; T N Wells; N W Lukacs; A E Proudfoot; S L Kunkel; T J Williams; P G Hellewell
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  The role of IL-33/ST2, IL-4, and eosinophils on the airway hyperresponsiveness induced by Strongyloides venezuelensis in BALB/c mice.

Authors:  Emilia Souza Araujo; Cintia Aparecida de Jesus Pereira; Ana Terezinha de Moura Pereira; João Marcelo Peixoto Moreira; Michelle Carvalho de Rezende; Jailza Lima Rodrigues; Mauro Martins Teixeira; Deborah Negrão-Corrêa
Journal:  Parasitol Res       Date:  2016-04-22       Impact factor: 2.289

4.  alpha(4) integrin-dependent eosinophil recruitment in allergic but not non-allergic inflammation.

Authors:  M M Teixeira; M K Robinson; A Shock; P G Hellewell
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Contrasting roles for RANTES and macrophage inflammatory protein-1 alpha (MIP-1 alpha) in a murine model of allergic peritonitis.

Authors:  A M Das; M N Ajuebor; R J Flower; M Perretti; S R McColl
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

6.  Mannheimia haemolytica and its leukotoxin cause neutrophil extracellular trap formation by bovine neutrophils.

Authors:  Nicole A Aulik; Katrina M Hellenbrand; Heather Klos; Charles J Czuprynski
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

7.  Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice.

Authors:  André Klein; Vanessa Pinho; Ana Letícia Alessandrini; Takao Shimizu; Satoshi Ishii; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 8.  [Eosinophilic dermatoses].

Authors:  G Wozel
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

9.  Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma.

Authors:  A G Rossi; C Haslett; N Hirani; A P Greening; I Rahman; C N Metz; R Bucala; S C Donnelly
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

Review 10.  Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease.

Authors:  P J Turner; J C Foreman
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.